Fundraising Fox
Nicholas Haft
InvestorManaging Director at OMX Ventures
New York, New York
Writes $500K – $15M checks · typically $7.8M
Find your path to Nicholas
Sign up to see every warm intro you have to Nicholas
- Paths you didn't know you had: your email and LinkedIn already hold routes to Nicholas. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Nick Haft is an investor at OMX Ventures. He previously served as the sole managing partner at Arcos Ventures, where he deployed more than $80M across 20+ bio-related companies, and he co-founded Delix Therapeutics, a startup developing therapies for psychiatric and neurological disorders. He holds a Bachelor of Science in Economics from the Wharton School at the University of Pennsylvania.
Contact· self-published, not guessed
Invests in
Biotech
Investments
Investor
10X GenomicsCompass PathwaysFinch TherapeuticsGinkgo BioworksImagenPendulum Therapeutics
Per the firm's website.
Colleagues at OMX Ventures
Network1
Investors connected to Nicholas in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Nicholas Haft?
- Nick Haft is an investor at OMX Ventures. He previously served as the sole managing partner at Arcos Ventures, where he deployed more than $80M across 20+ bio-related companies, and he co-founded Delix Therapeutics, a startup developing therapies for psychiatric and neurological disorders. He holds a Bachelor of Science in Economics from the Wharton School at the University of Pennsylvania.
- Where does Nicholas Haft work?
- Nicholas Haft is Managing Director at OMX Ventures.
- What does Nicholas Haft invest in?
- Nicholas Haft invests in Biotech.
- What check size does Nicholas Haft write?
- Nicholas Haft typically writes checks of $500K – $15M.
- What companies has Nicholas Haft invested in?
- Investments tracked here include 10X Genomics, Compass Pathways, Finch Therapeutics, Ginkgo Bioworks, Imagen, Pendulum Therapeutics.
About this profile. Compiled from public sources — OMX Ventures's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights